NCT06148870

Comparison of Efficacy Between Two Myopia Control Lenses

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 50 (estimated)
• Sponsor: Essilor International · Industry
• Sex: All
• Age: 6 Years – 11 Years
• Healthy volunteers: Accepted

Summary

This is a one-year, mono-centre, randomize, double-masked, monocular cross-over clinical trial designed to test and compare the efficacy of the new lens design in slowing down the increase of axial length and controlling myopia progression.

Detailed description

The clinical trial aims to assess the safety and efficacy of a test lens, designed to modify the amount of myopic control signal on the retina without compromising vision. The primary goal of this clinical trial is to evaluate the effectiveness of the test lens in slowing down the increase of axial length and controlling myopia progression compared to the reference lens design.

Conditions

• Myopia

Interventions

Type	Name	Description
DEVICE	Myopia Control Lens-1 (MCL1)	The MCL1, is a myopia control lens that corrects refractive error and simultaneously creates myopia control signals. It will be worn on one eye for 6 months.
DEVICE	Myopia Control Lens-2 (MCL2)	The MCL2, is a myopia control lens that corrects refractive error and simultaneously creates myopia control signals. It will be worn on the contralateral eye for 6 months.

Timeline

• Start date: 2023-11-29
• Primary completion: 2025-02-01
• Completion: 2025-04-01
• First posted: 2023-11-28
• Last updated: 2024-02-20

Locations

1 site across 1 country: Singapore